ODXX

Genomic Health, Inc.

Application Filed: 2019-10-02
Trademark Application Details
Trademark Logo ODXX

Mark For: ODXX™ trademark registration is intended to cover the categories of assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in the field of cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing. [all]

Status

2020-11-09 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88639685
Mark Literal ElementsODXX
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-05-05
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 001: Raw or Partly Prepared Materials
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 010: Fertilizers
  • 026: Measuring and Scientific Appliances
  • 046: Foods and Ingredients of Foods
Primary International Class
  • 001 - Primary Class
  • (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMargaret McHugh
Attorney Docket Number1159893
Law Office AssignedL20
Employee NameCHOSID, ROBIN S

Timeline

2019-10-02Application Filed
2019-11-19Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
2019-11-19Status: Live/Pending
2019-11-19Transaction Date
2020-03-10Published
2020-05-05Location: INTENT TO USE SECTION
2020-09-14Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Genomic Health, Inc.
Address301 Penobscot Drive Redwood City, CALIFORNIA UNITED STATES 94063
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Attorney of Record

MARGARET MCHUGH
KILPATRICK TOWNSEND & STOCKTON LLP
MAILSTOP IP DOCKETING-22
1100 PEACHTREE STREET NE, SUITE 2800
ATLANTA, GA 30309

Good, Services, and Codes


IC 001. US 001 005 006 010 026 046. G & S: Assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in the field of cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing
IC 005. US 006 018 044 046 051 052. G & S: Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical purposes consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for treatment purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer, for treatment purposes; diagnostic agents, preparations and substances for medical purposes
IC 042. US 100 101. G & S: Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
IC 044. US 100 101. G & S: Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0011assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-09-16
TEAS EXTENSION RECEIVED2020-09-14
EXTENSION 1 GRANTED2020-09-1498765
EXTENSION 1 FILED2020-09-1498765
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-06-19
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-06-19
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-06-19
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-06-19
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-06-1988888
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-05-05
PUBLISHED FOR OPPOSITION2020-03-10
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-03-10
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-02-19
APPROVED FOR PUB - PRINCIPAL REGISTER2020-02-06
TEAS/EMAIL CORRESPONDENCE ENTERED2020-02-0470629
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-02-0470629
ASSIGNED TO LIE2020-01-2970629
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-01-23
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-11-196325
NON-FINAL ACTION WRITTEN2019-11-1977654
NON-FINAL ACTION E-MAILED2019-11-196325
ASSIGNED TO EXAMINER2019-11-1177654
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-10-06
NEW APPLICATION ENTERED IN TRAM2019-10-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed